Integrating Patient-Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Incorporating Patient-Reported Quality Metrics in Systemic Lupus Erythematosus: Creation of the Implementation Guide by the American College of Rheumatology
To investigate the successes and challenges of implementing patient-reported outcome measures (PROMs) in systemic lupus erythematosus (SLE) clinical care and to develop an implementation guide for their integration.
Approach:
Study Design: Qualitative semistructured interviews guided by the Consolidated Framework for Implementation Research (CFIR) were conducted with clinicians and practice staff from five rheumatology practices.
Data Collection: Practices implemented workflows to collect SLE PROMs for at least 50 consecutive patients, focusing on physical function and depression assessments.
Implementation Guide Development: A consensus-building approach was used to synthesize findings and create the SLE Quality Measures Implementation Guide, an open-source resource for integrating PROMs into routine practice.
Key Findings:
Barriers and facilitators to PROM collection were identified through qualitative interviews with practice staff.
The SLE Quality Measures Implementation Guide provides practical strategies for integrating PROMs into clinical workflows.
Interpretation:
Incorporating PROMs into SLE care can enhance understanding of patient experiences and improve clinical decision-making.
Limitations:
The study was limited to five practices, which may not represent all rheumatology settings.
Data collection was restricted to a specific electronic health record system, potentially affecting generalizability.
Conclusion:
The study provides a framework for the implementation of PROMs in clinical practice.
Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.